Fatty Acid Synthase Confers Tamoxifen Resistance to ER+/HER2+ Breast Cancer

SIMPLE SUMMARY: Overactivation of the human epidermal growth factor receptor 2 (HER2) is one of the main drivers of tamoxifen resistance in estrogen receptor (ER)-positive breast cancer patients. Combined targeting of HER2 and ER, however, has yielded disappointing results in the clinical setting. T...

Descripción completa

Detalles Bibliográficos
Autores principales: Menendez, Javier A., Papadimitropoulou, Adriana, Vander Steen, Travis, Cuyàs, Elisabet, Oza-Gajera, Bharvi P., Verdura, Sara, Espinoza, Ingrid, Vellon, Luciano, Mehmi, Inderjit, Lupu, Ruth
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7961649/
https://www.ncbi.nlm.nih.gov/pubmed/33800852
http://dx.doi.org/10.3390/cancers13051132

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7961649/
https://www.ncbi.nlm.nih.gov/pubmed/33800852
http://dx.doi.org/10.3390/cancers13051132

Ejemplares similares